Millipore Sigma Vibrant Logo

475851 Mitaplatin - Calbiochem

Mitaplatin - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: c,c,t-[Pt(NH₃)₂Cl₂(O₂CCHCl₂)₂]

View Products on Sigmaaldrich.com
475851
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Key Spec Table

      Empirical Formula
      C₁₀H₂₂Cl₆N₄O₆Pt
      Description
      Overview

      This product has been discontinued.



      A cell-permeable Pt(IV) compound that, upon reduction inside cells, yields two molecules of the PDK (pyruvate dehydrogenase kinase) inhibitor DCA/dichloroacetate and one molecule of the apoptosis inducer Cisplatin (Cat. No. 232120). While the dual prodrug nature of Mitaplatin is shown to result in increased cell killing than Cisplatin in the human ovarian carcinoma A2780/CP70 cultures (IC50 = 3.34 and 6.0, respectively), the anticancer potency of Mitaplatin is often weaker than Cisplatin in other cancer cells tested, presumably due to insufficient prodrug reduction in these cells.

      Note: Carboplatin, Cisplatin, and other platinum drugs are reported to be rendered inactive due to ligand displacement by the nucleophilic sulfur of DMSO. Solubilization with DMSO prior to culture treatment is not recommended.
      Catalogue Number475851
      Brand Family Calbiochem®
      Synonymsc,c,t-[Pt(NH₃)₂Cl₂(O₂CCHCl₂)₂]
      References
      ReferencesHall, M.D., et al. 2014. Cancer Res. In press.
      Dhar, S., and Lippard, S.J., 2009. Proc. Natl. Acad. Sci. USA 106, 22199.
      Product Information
      FormOff-white to cream solid
      Hill FormulaC₁₀H₂₂Cl₆N₄O₆Pt
      Chemical formulaC₁₀H₂₂Cl₆N₄O₆Pt
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by NMR
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 22-36-45

      Do not breathe dust.
      Wear suitable protective clothing.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C. Use only fresh DMSO for reconstitution.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      475851 0

      Documentation

      Mitaplatin - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Mitaplatin - Calbiochem Analysenzertifikate

      TitelChargennummer
      475851

      Literatur

      Übersicht
      Hall, M.D., et al. 2014. Cancer Res. In press.
      Dhar, S., and Lippard, S.J., 2009. Proc. Natl. Acad. Sci. USA 106, 22199.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-July-2014 JSW
      Synonymsc,c,t-[Pt(NH₃)₂Cl₂(O₂CCHCl₂)₂]
      DescriptionA cell-permeable Pt(IV) compound that, upon reduction inside cells, yields two molecules of the PDK (pyruvate dehydrogenase kinase) inhibitor DCA/dichloroacetate and one molecule of the apoptosis inducer Cisplatin (Cat. No. 232120). While the dual prodrug nature of Mitaplatin is shown to result in increased cell killing than Cisplatin in the human ovarian carcinoma A2780/CP70 cultures (IC50 = 3.34 and 6.0, respectively), the anticancer potency of Mitaplatin is often weaker than Cisplatin in other cancer cells tested, presumably due to insufficient prodrug reduction in these cells.

      Note: Carboplatin, Cisplatin, and other platinum drugs are reported to be rendered inactive due to ligand displacement by the nucleophilic sulfur of DMSO. Solubilization with DMSO prior to culture treatment is not recommended.
      FormOff-white to cream solid
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₁₀H₂₂Cl₆N₄O₆Pt
      Structure formulaStructure formula
      Purity≥95% by NMR
      SolubilityDMSO (50 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C. Use only fresh DMSO for reconstitution.
      Toxicity Harmful
      ReferencesHall, M.D., et al. 2014. Cancer Res. In press.
      Dhar, S., and Lippard, S.J., 2009. Proc. Natl. Acad. Sci. USA 106, 22199.